Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128721) titled 'A Multimodal Deep Learning Model for Predicting Response to Neoadjuvant Chemotherapy Combined with Immunotherapy in Esophageal Cancer' on July 24.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Second Xiangya Hospital of Central South University
Condition:
Esophageal cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Locally advanced esophageal cancer patients receiving neoadjuvant chemotherapy combined with immunotherapy:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showp...